Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes
Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes
复制标题
DOI:
10.1016/j.intimp.2010.03.008
复制
发表时间:
2010-06-01
影响因子:
5.6
通讯作者:
Pontillo, Alessandra
中科院分区:
文献类型:
--
作者:
Marcuzzi, Annalisa;Tommasini, Alberto;Pontillo, Alessandra
The inhibition of mevalonate pathway through genetic defects (mevalonate kinase deficiency. MKD) or pharmacologic drugs (aminobisphosphonates) causes a shortage of intermediate compounds and, in particular, of geranylgeranyl-pyrophosphate (GGPP) associated to the activation of caspase-1 and IL-1 beta release. Geraniol (GOH), farnesol (FOH),geranylgeraniol (GGOH) and menthol (MOH), due to their isoprenoid structure, are supposed to enter the mevalonate pathway and to by-pass the biochemical block, reconstituting the pathway. Considering the already known side effects of aminobisphosphonates, and the lack of a specific treatment for MKD, we evaluated the impact of these natural isoprenoids compounds in a RAW cell lines chemically treated with the aminobisphosphonate alendronate, and in monocytes isolated from 2 patients affected by MKD. GOH, FOH, GGOH and MOH were all capable to diminish inflammatory marker levels induced by LPS. These natural isoprenoids could be proposed as novel therapeutic approach for the still orphan drug MKD, but also considered for the evaluation of possible inflammatory side effects of aminobisphosphonates. (C) 2010 Elsevier B.V. All rights reserved.